Stock Events

Stock Events

Silexion Therapeutics (SLXN) Q4 2024 Earnings

14NovConfirmed

Q1 1

Q3 2024

Q4 2024

-7.4

-4.97

-2.54

-0.11

Details

Expected EPS

-7.38

Actual EPS

-7.4

Surprise EPS

-0.02

Surprise Percent

+0.27%

Description

Silexion Therapeutics (SLXN) has reported earnings of -7.4 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.